date:Apr 28, 2012
rosol and oleuropein for treating inflammatory conditions.
This complements process and composition patents it has already secured and gives CreAgri broad protection, said Pontoniere.
The allowed claims encompass inflammatory processes in cardiovascular, autoimmune diseasesincluding psoriasis and eczemaneurodegenerative and respiratory diseases and many other human ailments having an underlying inflammatory component.
While CreAgri had contacted a number of companies it believedmight be violatin